Delivery Order SPE2DR25D1017-SPE2DR26F9AZC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,899.60 to AmerisourceBergen Drug Corp for Methenamine Hippurate 1 GM tablets (100-count packages) on August 19, 2025, with completion scheduled for August 20, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,589.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Methenamine Hippurate 1 gram tablets (100 count). The contract is set to be completed by October 24, 2025, and represents a non-set-aside competitive award. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,183.16 to AmerisourceBergen Drug Corp for Methenamine Hippurate 1 GM tablets (100-count) on December 9, 2025, with an ultimate completion date of December 10, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methazolamide 50 mg tablets (100-count units) with a contract value of $4,031.07. This competitively awarded, non-set-aside delivery order is classified as a firm fixed-price contract with an ultimate completion date of August 7, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery order is...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,132.05 by the Defense Logistics Agency's Medical Supply Chain on June 3, 2025, for the supply of Methyldopa 250 mg tablets in quantities of 90. This competitively awarded, firm fixed-price contract carries an ultimate completion date of June 4, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Methylergonovine 0.2 mg tablets (28-count) with a firm fixed price ceiling value of $1,547.44. The contract was competitively awarded with no set-aside designation and is scheduled for ultimate completion on August 22, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $3,543.41 by the Defense Logistics Agency to supply Mesalamine DR 1.2 GM tablets (120-count units). The contract, awarded on November 6, 2025, with completion scheduled for November 7, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation, indicating competitive award. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $20,578.50 on August 4, 2025, for the supply of Methamphetamine HCL tablets (5mg). This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order with an ultimate completion date of August 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Methylergonovine 0.2 mg tablets in quantities of 12 units. This firm fixed-price delivery order, valued at $2,498.25, represents a non-competitive set-aside award with an ultimate completion date of December 3, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 25, 2025, for the supply of Methyldopa 250 mg tablets (180 count) valued at $2,334.14. This firm fixed-price contract, which is due for completion by August 26, 2025, was awarded without a set-aside designation through competitive procedures. The award is funded by the Defense Logistics Agency's Medical Supply Chain, reflecting the company's role...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9AZCDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,882.35 for Methenamine Hippurate 1 gram tablets (100-count) with a completion date of December 9, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a broad portfolio of medications and medical commodities to support military healthcare programs and other government systems. The Methenamine Hippurate delivery supports DLA's medical supply chain operations and represents routine pharmaceutical procurement for federal healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 12/7/25 |